NIH VideoCast - Cartilage Preservation and Restoration for Knee Osteoarthritis

Skip Navigation

Cartilage Preservation and Restoration for Knee Osteoarthritis

Loading... Loading video...

549 Views

Air date:	Thursday, September 22, 2022, 11:00:00 AM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 549 (240 Live, 309 On-demand)
Category:	Conferences
Runtime:	06:07:06
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	Over the last decade, a variety of regenerative medicine approaches that either preserve articular cartilage in people who started with a focal cartilage injury and thus are at a higher risk of developing knee osteoarthritis (OA) or restore defective articular cartilage in patients with symptomatic knee OA have been investigated. Recognizing the great promise of regenerative medicine for the treatment of knee OA, the importance of promoting scientific rigor and protecting patient safety, and the timing for the extramural community to adapt to new FDA guidance, NIAMS is organizing a roundtable to engage stakeholders to discuss challenges, gaps, and opportunities regarding regenerative medicine approaches for cartilage preservation and restoration in knee OA and where and how NIAMS could play a role and move the field forward. Stakeholders who will participate in the roundtable include investigators with expertise in regenerative medicine, experts in clinical treatment of knee OA, and FDA representatives.

NLM Title:	Cartilage preservation and restoration for knee osteoarthritis / NIAMS, NIH.
Author:	NIAMS Roundtable on Cartilage Preservation and Restoration in Knee Osteoarthritis (Conference) National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.), National Institutes of Health (U.S.),
Publisher:
Abstract:	(CIT): Over the last decade, a variety of regenerative medicine approaches that either preserve articular cartilage in people who started with a focal cartilage injury and thus are at a higher risk of developing knee osteoarthritis (OA) or restore defective articular cartilage in patients with symptomatic knee OA have been investigated. Recognizing the great promise of regenerative medicine for the treatment of knee OA, the importance of promoting scientific rigor and protecting patient safety, and the timing for the extramural community to adapt to new FDA guidance, NIAMS is organizing a roundtable to engage stakeholders to discuss challenges, gaps, and opportunities regarding regenerative medicine approaches for cartilage preservation and restoration in knee OA and where and how NIAMS could play a role and move the field forward. Stakeholders who will participate in the roundtable include investigators with expertise in regenerative medicine, experts in clinical treatment of knee OA, and FDA representatives.
Subjects:	Cartilage, Articular--surgery Osteoarthritis, Knee--therapy Regenerative Medicine Therapies, Investigational--methods United States
Publication Types:	Congress Webcast

NLM Classification:	WE 870
NLM ID:	9918503179706676
CIT Live ID:	45004
Permanent link:	https://videocast.nih.gov/watch=45004

Related Videos...